ID   CYB_HUMAN               Reviewed;         380 AA.
AC   P00156; Q34786; Q8HBR6; Q8HNQ0; Q8HNQ1; Q8HNQ9; Q8HNR4; Q8HNR7;
AC   Q8W7V8; Q8WCV9; Q8WCY2; Q8WCY7; Q8WCY8; Q9B1A6; Q9B1B6; Q9B1B8;
AC   Q9B1D4; Q9B1X6; Q9B2V0; Q9B2V8; Q9B2W0; Q9B2W3; Q9B2W8; Q9B2X1;
AC   Q9B2X7; Q9B2X9; Q9B2Y3; Q9B2Z0; Q9B2Z4; Q9T6H6; Q9T9Y0; Q9TEH4;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   03-OCT-2012, sequence version 2.
DT   10-MAY-2017, entry version 190.
DE   RecName: Full=Cytochrome b;
DE   AltName: Full=Complex III subunit 3;
DE   AltName: Full=Complex III subunit III;
DE   AltName: Full=Cytochrome b-c1 complex subunit 3;
DE   AltName: Full=Ubiquinol-cytochrome-c reductase complex cytochrome b subunit;
GN   Name=MT-CYB; Synonyms=COB, CYTB, MTCYB;
OS   Homo sapiens (Human).
OG   Mitochondrion.
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=7219534; DOI=10.1038/290457a0;
RA   Anderson S., Bankier A.T., Barrell B.G., de Bruijn M.H.L.,
RA   Coulson A.R., Drouin J., Eperon I.C., Nierlich D.P., Roe B.A.,
RA   Sanger F., Schreier P.H., Smith A.J.H., Staden R., Young I.G.;
RT   "Sequence and organization of the human mitochondrial genome.";
RL   Nature 290:457-465(1981).
RN   [2]
RP   SEQUENCE REVISION TO 7.
RX   PubMed=10508508; DOI=10.1038/13779;
RA   Andrews R.M., Kubacka I., Chinnery P.F., Lightowlers R.N.,
RA   Turnbull D.M., Howell N.;
RT   "Reanalysis and revision of the Cambridge reference sequence for human
RT   mitochondrial DNA.";
RL   Nat. Genet. 23:147-147(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-7 AND
RP   CARDIOMYOPATHY HIS-255.
RC   TISSUE=Heart;
RX   PubMed=7623448; DOI=10.1007/BF00711378;
RA   Marin-Garcia J., Ananthakrishnan R., Gonzalvo A., Goldenthal M.J.;
RT   "Novel mutations in mitochondrial cytochrome b in fatal post partum
RT   cardiomyopathy.";
RL   J. Inherit. Metab. Dis. 18:77-78(1995).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS ILE-7; THR-191;
RP   ALA-194 AND THR-229.
RC   TISSUE=Placenta;
RX   PubMed=7530363; DOI=10.1073/pnas.92.2.532;
RA   Horai S., Hayasaka K., Kondo R., Tsugane K., Takahata N.;
RT   "Recent African origin of modern humans revealed by complete sequences
RT   of hominoid mitochondrial DNAs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:532-536(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-378, AND VARIANTS ILE-7; SER-8;
RP   LEU-18; VAL-39; THR-78; THR-122; ALA-123; THR-153; ALA-194; THR-229;
RP   ILE-236; THR-306; THR-329; VAL-334; MET-353; MET-356 AND ILE-368.
RX   PubMed=11130070; DOI=10.1038/35047064;
RA   Ingman M., Kaessmann H., Paeaebo S., Gyllensten U.;
RT   "Mitochondrial genome variation and the origin of modern humans.";
RL   Nature 408:708-713(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-378, AND VARIANTS ILE-7; SER-8;
RP   LEU-18; THR-122; VAL-164; 189-VAL-THR-190; ALA-194; THR-229; ILE-236;
RP   THR-330; ALA-360 AND ILE-368.
RX   PubMed=11553319; DOI=10.1186/1471-2156-2-13;
RA   Maca-Meyer N., Gonzalez A.M., Larruga J.M., Flores C., Cabrera V.M.;
RT   "Major genomic mitochondrial lineages delineate early human
RT   expansions.";
RL   BMC Genet. 2:13-13(2001).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-378, AND VARIANTS ILE-7;
RP   THR-39; VAL-78; THR-191; ALA-194 AND ASP-260.
RX   PubMed=12022039; DOI=10.1086/341358;
RA   Silva W.A. Jr., Bonatto S.L., Holanda A.J., Ribeiro-Dos-Santos A.K.,
RA   Paixao B.M., Goldman G.H., Abe-Sandes K., Rodriguez-Delfin L.,
RA   Barbosa M., Paco-Larson M.L., Petzl-Erler M.L., Valente V.,
RA   Santos S.E., Zago M.A.;
RT   "Mitochondrial genome diversity of native Americans supports a single
RT   early entry of founder populations into America.";
RL   Am. J. Hum. Genet. 71:187-192(2002).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 269-380.
RC   TISSUE=Lymphoblast;
RX   PubMed=6100559;
RA   Spurr N.K., Bodmer W.F.;
RT   "Serendipitous cloning of a mitochondrial cDNA and its polymorphism.";
RL   Mol. Biol. Med. 2:239-249(1984).
RN   [9]
RP   DISEASE.
RX   PubMed=11047755; DOI=10.1086/316900;
RA   Keightley J.A., Anitori R., Burton M.D., Quan F., Buist N.R.M.,
RA   Kennaway N.G.;
RT   "Mitochondrial encephalomyopathy and complex III deficiency associated
RT   with a stop-codon mutation in the cytochrome b gene.";
RL   Am. J. Hum. Genet. 67:1400-1410(2000).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [11]
RP   VARIANTS ILE-7 AND PRO-87.
RX   PubMed=1757091; DOI=10.1007/BF00206061;
RA   Marzuki S., Noer A.S., Lertrit P., Thyagarajan D., Kapsa R.,
RA   Utthanaphol P., Byrne E.;
RT   "Normal variants of human mitochondrial DNA and translation products:
RT   the building of a reference data base.";
RL   Hum. Genet. 88:139-145(1991).
RN   [12]
RP   VARIANTS LHON ASN-171 AND MET-356.
RX   PubMed=1732158;
RA   Brown M.D., Voljavec A.S., Lott M.T., Torroni A., Yang C.C.,
RA   Wallace D.C.;
RT   "Mitochondrial DNA complex I and III mutations associated with Leber's
RT   hereditary optic neuropathy.";
RL   Genetics 130:163-173(1992).
RN   [13]
RP   VARIANT EXERCISE INTOLERANCE ASP-290.
RX   PubMed=8910895; DOI=10.1006/mcpr.1996.0053;
RA   Dumoulin R., Sagnol I., Ferlin T., Bozon D., Stepien G., Mousson B.;
RT   "A novel gly290asp mitochondrial cytochrome b mutation linked to a
RT   complex III deficiency in progressive exercise intolerance.";
RL   Mol. Cell. Probes 10:389-391(1996).
RN   [14]
RP   VARIANT MM GLU-339.
RX   PubMed=9818877; DOI=10.1212/WNL.51.5.1444;
RA   Andreu A.L., Bruno C., Shanske S., Shtilbans A., Hirano M.,
RA   Krishna S., Hayward L., Systrom D.S., Brown R.H. Jr., Dimauro S.;
RT   "Missense mutation in the mtDNA cytochrome b gene in a patient with
RT   myopathy.";
RL   Neurology 51:1444-1447(1998).
RN   [15]
RP   VARIANTS COLORECTAL CANCER HIS-80 AND LEU-276.
RX   PubMed=9806551; DOI=10.1038/3108;
RA   Polyak K., Li Y., Zhu H., Lengauer C., Willson J.K.V., Markowitz S.D.,
RA   Trush M.A., Kinzler K.W., Vogelstein B.;
RT   "Somatic mutations of the mitochondrial genome in human colorectal
RT   tumours.";
RL   Nat. Genet. 20:291-293(1998).
RN   [16]
RP   VARIANT HCM GLU-166, AND VARIANTS ILE-7; SER-8; LEU-18; ALA-194;
RP   ILE-236 AND THR-316.
RX   PubMed=10453733; DOI=10.1007/s004390050988;
RA   Valnot I., Kassis J., Chretien D., de Lonlay P., Parfait B.,
RA   Munnich A., Kachaner J., Rustin P., Roetig A.;
RT   "A mitochondrial cytochrome b mutation but no mutations of nuclearly
RT   encoded subunits in ubiquinol cytochrome c reductase (complex III)
RT   deficiency.";
RL   Hum. Genet. 104:460-466(1999).
RN   [17]
RP   VARIANTS MM SER-34 AND 251-GLY--LEU-258 DEL.
RX   PubMed=10502593; DOI=10.1056/NEJM199909303411404;
RA   Andreu A.L., Hanna M.G., Reichmann H., Bruno C., Penn A.S., Tanji K.,
RA   Pallotti F., Iwata S., Bonilla E., Lach B., Morgan-Hughes J.,
RA   DiMauro S.;
RT   "Exercise intolerance due to mutations in the cytochrome b gene of
RT   mitochondrial DNA.";
RL   N. Engl. J. Med. 341:1037-1044(1999).
RN   [18]
RP   VARIANT CMIH ASP-251.
RX   PubMed=10960495; DOI=10.1203/00006450-200009000-00008;
RA   Andreu A.L., Checcarelli N., Iwata S., Shanske S., DiMauro S.;
RT   "A missense mutation in the mitochondrial cytochrome b gene in a
RT   revisited case with histiocytoid cardiomyopathy.";
RL   Pediatr. Res. 48:311-314(2000).
RN   [19]
RP   VARIANT MULTISYSTEM DISORDER CYS-278.
RX   PubMed=11601507; DOI=10.1002/ana.1224;
RA   Wibrand F., Ravn K., Schwartz M., Rosenberg T., Horn N., Vissing J.;
RT   "Multisystem disorder associated with a missense mutation in the
RT   mitochondrial cytochrome b gene.";
RL   Ann. Neurol. 50:540-543(2001).
RN   [20]
RP   VARIANT EXERCISE INTOLERANCE PRO-151.
RX   PubMed=11464242; DOI=10.1038/sj.ejhg.5200678;
RA   Legros F., Chatzoglou E., Frachon P., de Baulny H.O., Laforet P.,
RA   Jardel C., Godinot C., Lombes A.;
RT   "Functional characterization of novel mutations in the human
RT   cytochrome b gene.";
RL   Eur. J. Hum. Genet. 9:510-518(2001).
RN   [21]
RP   VARIANT EXERCICE INTOLERANCE PRO-35.
RX   PubMed=11891837; DOI=10.1002/ana.10151;
RA   Schuelke M., Krude H., Finckh B., Mayatepek E., Janssen A.,
RA   Schmelz M., Trefz F., Trijbels F., Smeitink J.;
RT   "Septo-optic dysplasia associated with a new mitochondrial cytochrome
RT   b mutation.";
RL   Ann. Neurol. 51:388-392(2002).
RN   [22]
RP   VARIANT SER-251.
RX   PubMed=12905068; DOI=10.1007/s00439-003-0983-8;
RA   Okura T., Koda M., Ando F., Niino N., Tanaka M., Shimokata H.;
RT   "Association of the mitochondrial DNA 15497G/A polymorphism with
RT   obesity in a middle-aged and elderly Japanese population.";
RL   Hum. Genet. 113:432-436(2003).
RN   [23]
RP   VARIANT [LARGE SCALE ANALYSIS] ILE-7, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
CC   -!- FUNCTION: Component of the ubiquinol-cytochrome c reductase
CC       complex (complex III or cytochrome b-c1 complex) that is part of
CC       the mitochondrial respiratory chain. The b-c1 complex mediates
CC       electron transfer from ubiquinol to cytochrome c. Contributes to
CC       the generation of a proton gradient across the mitochondrial
CC       membrane that is then used for ATP synthesis.
CC       {ECO:0000250|UniProtKB:P00157}.
CC   -!- COFACTOR:
CC       Name=heme; Xref=ChEBI:CHEBI:30413;
CC         Evidence={ECO:0000250|UniProtKB:P00157};
CC       Note=Binds 2 heme groups non-covalently.
CC       {ECO:0000250|UniProtKB:P00157};
CC   -!- SUBUNIT: The cytochrome bc1 complex contains 11 subunits: 3
CC       respiratory subunits (MT-CYB, CYC1 and UQCRFS1), 2 core proteins
CC       (UQCRC1 and UQCRC2) and 6 low-molecular weight proteins
CC       (UQCRH/QCR6, UQCRB/QCR7, UQCRQ/QCR8, UQCR10/QCR9, UQCR11/QCR10 and
CC       a cleavage product of UQCRFS1). This cytochrome bc1 complex then
CC       forms a dimer. {ECO:0000250|UniProtKB:P00157}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane
CC       {ECO:0000250|UniProtKB:P00157}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:P00157}.
CC   -!- DISEASE: Note=Defects in MT-CYB are a rare cause of mitochondrial
CC       dysfunction underlying different myopathies. They include
CC       mitochondrial encephalomyopathy, hypertrophic cardiomyopathy
CC       (HCM), and sporadic mitochondrial myopathy (MM). In mitochondrial
CC       myopathy, exercise intolerance is the predominant symptom.
CC       Additional features include lactic acidosis, muscle weakness
CC       and/or myoglobinuria. Defects in MTCYB are also found in cases of
CC       exercise intolerance accompanied by deafness, mental retardation,
CC       retinitis pigmentosa, cataract, growth retardation, epilepsy
CC       (multisystem disorder). {ECO:0000269|PubMed:11047755,
CC       ECO:0000269|PubMed:11601507}.
CC   -!- DISEASE: Cardiomyopathy, infantile histiocytoid (CMIH)
CC       [MIM:500000]: A heart disease characterized by the presence of
CC       pale granular foamy histiocyte-like cells within the myocardium.
CC       It usually affects children younger than 2 years of age, with a
CC       clear predominance of females over males. Infants present with
CC       dysrhythmia or cardiac arrest. The clinical course is usually
CC       fulminant, sometimes simulating sudden infant death syndrome.
CC       {ECO:0000269|PubMed:10960495}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Leber hereditary optic neuropathy (LHON) [MIM:535000]: A
CC       maternally inherited disease resulting in acute or subacute loss
CC       of central vision, due to optic nerve dysfunction. Cardiac
CC       conduction defects and neurological defects have also been
CC       described in some patients. LHON results from primary
CC       mitochondrial DNA mutations affecting the respiratory chain
CC       complexes. {ECO:0000269|PubMed:1732158}. Note=The disease is
CC       caused by mutations affecting distinct genetic loci, including the
CC       gene represented in this entry.
CC   -!- MISCELLANEOUS: Heme 1 (or BL or b562) is low-potential and absorbs
CC       at about 562 nm, and heme 2 (or BH or b566) is high-potential and
CC       absorbs at about 566 nm. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the cytochrome b family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00967, ECO:0000255|PROSITE-
CC       ProRule:PRU00968}.
CC   -!- CAUTION: The full-length protein contains only eight transmembrane
CC       helices, not nine as predicted by bioinformatics tools.
CC       {ECO:0000250|UniProtKB:P00157}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; V00662; CAA24038.1; -; Genomic_DNA.
DR   EMBL; J01415; AAB58955.3; -; Genomic_DNA.
DR   EMBL; U09500; AAA19775.1; -; Genomic_DNA.
DR   EMBL; D38112; BAA77674.1; -; Genomic_DNA.
DR   EMBL; AF346963; AAK17219.1; -; Genomic_DNA.
DR   EMBL; AF346964; AAK17232.2; -; Genomic_DNA.
DR   EMBL; AF346965; AAK17245.2; -; Genomic_DNA.
DR   EMBL; AF346966; AAK17258.1; -; Genomic_DNA.
DR   EMBL; AF346967; AAK17271.2; -; Genomic_DNA.
DR   EMBL; AF346968; AAK17284.2; -; Genomic_DNA.
DR   EMBL; AF346969; AAK17297.2; -; Genomic_DNA.
DR   EMBL; AF346970; AAK17310.2; -; Genomic_DNA.
DR   EMBL; AF346971; AAK17323.2; -; Genomic_DNA.
DR   EMBL; AF346972; AAK17336.2; -; Genomic_DNA.
DR   EMBL; AF346973; AAK17349.2; -; Genomic_DNA.
DR   EMBL; AF346974; AAK17362.2; -; Genomic_DNA.
DR   EMBL; AF346975; AAK17375.2; -; Genomic_DNA.
DR   EMBL; AF346976; AAK17388.1; -; Genomic_DNA.
DR   EMBL; AF346977; AAK17401.1; -; Genomic_DNA.
DR   EMBL; AF346978; AAK17414.1; -; Genomic_DNA.
DR   EMBL; AF346979; AAK17427.1; -; Genomic_DNA.
DR   EMBL; AF346980; AAK17440.2; -; Genomic_DNA.
DR   EMBL; AF346981; AAK17453.2; -; Genomic_DNA.
DR   EMBL; AF346982; AAK17466.1; -; Genomic_DNA.
DR   EMBL; AF346983; AAK17479.1; -; Genomic_DNA.
DR   EMBL; AF346984; AAK17492.2; -; Genomic_DNA.
DR   EMBL; AF346985; AAK17505.2; -; Genomic_DNA.
DR   EMBL; AF346986; AAK17518.2; -; Genomic_DNA.
DR   EMBL; AF346987; AAK17531.2; -; Genomic_DNA.
DR   EMBL; AF346988; AAK17544.1; -; Genomic_DNA.
DR   EMBL; AF346989; AAK17557.2; -; Genomic_DNA.
DR   EMBL; AF346990; AAK17570.1; -; Genomic_DNA.
DR   EMBL; AF346991; AAK17583.2; -; Genomic_DNA.
DR   EMBL; AF346992; AAK17596.2; -; Genomic_DNA.
DR   EMBL; AF346993; AAK17609.2; -; Genomic_DNA.
DR   EMBL; AF346994; AAK17622.2; -; Genomic_DNA.
DR   EMBL; AF346995; AAK17635.2; -; Genomic_DNA.
DR   EMBL; AF346996; AAK17648.2; -; Genomic_DNA.
DR   EMBL; AF346997; AAK17661.2; -; Genomic_DNA.
DR   EMBL; AF346998; AAK17674.2; -; Genomic_DNA.
DR   EMBL; AF346999; AAK17687.2; -; Genomic_DNA.
DR   EMBL; AF347000; AAK17700.1; -; Genomic_DNA.
DR   EMBL; AF347001; AAK17713.2; -; Genomic_DNA.
DR   EMBL; AF347002; AAK17726.2; -; Genomic_DNA.
DR   EMBL; AF347003; AAK17739.2; -; Genomic_DNA.
DR   EMBL; AF347004; AAK17752.2; -; Genomic_DNA.
DR   EMBL; AF347005; AAK17765.2; -; Genomic_DNA.
DR   EMBL; AF347006; AAK17778.2; -; Genomic_DNA.
DR   EMBL; AF347007; AAK17791.2; -; Genomic_DNA.
DR   EMBL; AF347008; AAK17804.2; -; Genomic_DNA.
DR   EMBL; AF347009; AAK17817.2; -; Genomic_DNA.
DR   EMBL; AF347010; AAK17830.2; -; Genomic_DNA.
DR   EMBL; AF347011; AAK17843.2; -; Genomic_DNA.
DR   EMBL; AF347012; AAK17856.2; -; Genomic_DNA.
DR   EMBL; AF347013; AAK17869.2; -; Genomic_DNA.
DR   EMBL; AF347014; AAK17882.2; -; Genomic_DNA.
DR   EMBL; AF347015; AAK17895.2; -; Genomic_DNA.
DR   EMBL; AF381981; AAL54394.1; -; Genomic_DNA.
DR   EMBL; AF381982; AAL54409.1; -; Genomic_DNA.
DR   EMBL; AF381983; AAL54422.1; -; Genomic_DNA.
DR   EMBL; AF381984; AAL54435.1; -; Genomic_DNA.
DR   EMBL; AF381985; AAL54448.1; -; Genomic_DNA.
DR   EMBL; AF381986; AAL54461.1; -; Genomic_DNA.
DR   EMBL; AF381987; AAL54474.1; -; Genomic_DNA.
DR   EMBL; AF381988; AAL54487.1; -; Genomic_DNA.
DR   EMBL; AF381989; AAL54500.1; -; Genomic_DNA.
DR   EMBL; AF381990; AAL54513.1; -; Genomic_DNA.
DR   EMBL; AF381991; AAL54526.1; -; Genomic_DNA.
DR   EMBL; AF381992; AAL54539.1; -; Genomic_DNA.
DR   EMBL; AF381993; AAL54552.1; -; Genomic_DNA.
DR   EMBL; AF381994; AAL54565.1; -; Genomic_DNA.
DR   EMBL; AF381995; AAL54578.1; -; Genomic_DNA.
DR   EMBL; AF381996; AAL54591.1; -; Genomic_DNA.
DR   EMBL; AF381997; AAL54604.1; -; Genomic_DNA.
DR   EMBL; AF381998; AAL54617.1; -; Genomic_DNA.
DR   EMBL; AF381999; AAL54630.1; -; Genomic_DNA.
DR   EMBL; AF382000; AAL54643.1; -; Genomic_DNA.
DR   EMBL; AF382001; AAL54656.1; -; Genomic_DNA.
DR   EMBL; AF382002; AAL54669.1; -; Genomic_DNA.
DR   EMBL; AF382003; AAL54682.1; -; Genomic_DNA.
DR   EMBL; AF382004; AAL54695.1; -; Genomic_DNA.
DR   EMBL; AF382005; AAL54708.1; -; Genomic_DNA.
DR   EMBL; AF382006; AAL54721.1; -; Genomic_DNA.
DR   EMBL; AF382007; AAL54734.1; -; Genomic_DNA.
DR   EMBL; AF382008; AAL54747.1; -; Genomic_DNA.
DR   EMBL; AF382009; AAL54760.1; -; Genomic_DNA.
DR   EMBL; AF382010; AAL54773.1; -; Genomic_DNA.
DR   EMBL; AF382011; AAL54786.1; -; Genomic_DNA.
DR   EMBL; AF382012; AAL54799.1; -; Genomic_DNA.
DR   EMBL; AF382013; AAL54812.1; -; Genomic_DNA.
DR   EMBL; AF465942; AAN14559.1; -; Genomic_DNA.
DR   EMBL; AF465945; AAN14592.1; -; Genomic_DNA.
DR   EMBL; AF465946; AAN14603.1; -; Genomic_DNA.
DR   EMBL; AF465947; AAN14614.1; -; Genomic_DNA.
DR   EMBL; AF465948; AAN14625.1; -; Genomic_DNA.
DR   EMBL; AF465949; AAN14636.1; -; Genomic_DNA.
DR   EMBL; AF465953; AAN14680.1; -; Genomic_DNA.
DR   EMBL; AF465956; AAN14713.1; -; Genomic_DNA.
DR   EMBL; AF465968; AAN14845.1; -; Genomic_DNA.
DR   EMBL; AF465971; AAN14878.1; -; Genomic_DNA.
DR   EMBL; AF465972; AAN14889.1; -; Genomic_DNA.
DR   EMBL; AF465973; AAN14900.1; -; Genomic_DNA.
DR   EMBL; AF465974; AAN14911.1; -; Genomic_DNA.
DR   EMBL; AF465975; AAN14922.1; -; Genomic_DNA.
DR   EMBL; AF465977; AAN14944.1; -; Genomic_DNA.
DR   EMBL; M28016; AAA31851.1; -; mRNA.
DR   PIR; A00151; CBHU.
DR   RefSeq; YP_003024038.1; NC_012920.1.
DR   ProteinModelPortal; P00156; -.
DR   SMR; P00156; -.
DR   BioGrid; 110619; 10.
DR   IntAct; P00156; 3.
DR   STRING; 9606.ENSP00000354554; -.
DR   BindingDB; P00156; -.
DR   DrugBank; DB08453; 2-NONYL-4-HYDROXYQUINOLINE N-OXIDE.
DR   DrugBank; DB07778; FAMOXADONE.
DR   DrugBank; DB07401; METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE.
DR   DrugBank; DB08330; METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE.
DR   DrugBank; DB08690; UBIQUINONE-2.
DR   iPTMnet; P00156; -.
DR   PhosphoSitePlus; P00156; -.
DR   DMDM; 408360043; -.
DR   EPD; P00156; -.
DR   PaxDb; P00156; -.
DR   PeptideAtlas; P00156; -.
DR   PRIDE; P00156; -.
DR   TopDownProteomics; P00156; -.
DR   Ensembl; ENST00000361789; ENSP00000354554; ENSG00000198727.
DR   GeneID; 4519; -.
DR   KEGG; hsa:4519; -.
DR   CTD; 4519; -.
DR   DisGeNET; 4519; -.
DR   GeneCards; MT-CYB; -.
DR   GeneReviews; MT-CYB; -.
DR   HGNC; HGNC:7427; MT-CYB.
DR   HPA; CAB032215; -.
DR   HPA; HPA068400; -.
DR   MalaCards; MT-CYB; -.
DR   MIM; 500000; phenotype.
DR   MIM; 516020; gene.
DR   MIM; 535000; phenotype.
DR   neXtProt; NX_P00156; -.
DR   OpenTargets; ENSG00000198727; -.
DR   Orphanet; 137675; Histiocytoid cardiomyopathy.
DR   Orphanet; 1460; Isolated CoQ-cytochrome C reductase deficiency.
DR   Orphanet; 104; Leber hereditary optic neuropathy.
DR   PharmGKB; PA31234; -.
DR   eggNOG; KOG4663; Eukaryota.
DR   eggNOG; COG1290; LUCA.
DR   GeneTree; ENSGT00390000017948; -.
DR   HOVERGEN; HBG017694; -.
DR   InParanoid; P00156; -.
DR   KO; K00412; -.
DR   OMA; FMDWVDA; -.
DR   OrthoDB; EOG091G0DW4; -.
DR   PhylomeDB; P00156; -.
DR   TreeFam; TF353088; -.
DR   Reactome; R-HSA-611105; Respiratory electron transport.
DR   GeneWiki; MT-CYB; -.
DR   GenomeRNAi; 4519; -.
DR   PRO; PR:P00156; -.
DR   Proteomes; UP000005640; Mitochondrion.
DR   Bgee; ENSG00000198727; -.
DR   ExpressionAtlas; P00156; baseline and differential.
DR   GO; GO:0031305; C:integral component of mitochondrial inner membrane; IEA:Ensembl.
DR   GO; GO:0005743; C:mitochondrial inner membrane; TAS:Reactome.
DR   GO; GO:0005750; C:mitochondrial respiratory chain complex III; NAS:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0009055; F:electron carrier activity; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0032403; F:protein complex binding; IEA:Ensembl.
DR   GO; GO:0008121; F:ubiquinol-cytochrome-c reductase activity; NAS:UniProtKB.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0042538; P:hyperosmotic salinity response; IEA:Ensembl.
DR   GO; GO:0006122; P:mitochondrial electron transport, ubiquinol to cytochrome c; TAS:Reactome.
DR   GO; GO:0046686; P:response to cadmium ion; IEA:Ensembl.
DR   GO; GO:0051592; P:response to calcium ion; IEA:Ensembl.
DR   GO; GO:0033590; P:response to cobalamin; IEA:Ensembl.
DR   GO; GO:0046688; P:response to copper ion; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0033762; P:response to glucagon; IEA:Ensembl.
DR   GO; GO:0009408; P:response to heat; IEA:Ensembl.
DR   GO; GO:0055093; P:response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0046689; P:response to mercury ion; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; IEA:Ensembl.
DR   CDD; cd00290; cytochrome_b_C; 1.
DR   CDD; cd00284; Cytochrome_b_N; 1.
DR   Gene3D; 1.20.810.10; -; 1.
DR   InterPro; IPR005798; Cyt_b/b6_C.
DR   InterPro; IPR005797; Cyt_b/b6_N.
DR   InterPro; IPR027387; Cytb/b6-like.
DR   InterPro; IPR030689; Cytochrome_b.
DR   InterPro; IPR016174; Di-haem_cyt_TM.
DR   Pfam; PF00032; Cytochrom_B_C; 1.
DR   Pfam; PF00033; Cytochrome_B; 1.
DR   PIRSF; PIRSF038885; COB; 1.
DR   SUPFAM; SSF81342; SSF81342; 1.
DR   SUPFAM; SSF81648; SSF81648; 1.
DR   PROSITE; PS51003; CYTB_CTER; 1.
DR   PROSITE; PS51002; CYTB_NTER; 1.
PE   1: Evidence at protein level;
KW   Cardiomyopathy; Cataract; Complete proteome; Deafness;
KW   Disease mutation; Electron transport; Heme; Iron;
KW   Leber hereditary optic neuropathy; Membrane; Metal-binding;
KW   Mitochondrion; Mitochondrion inner membrane; Polymorphism;
KW   Reference proteome; Respiratory chain; Transmembrane;
KW   Transmembrane helix; Transport; Ubiquinone.
FT   CHAIN         1    380       Cytochrome b.
FT                                /FTId=PRO_0000061045.
FT   TRANSMEM     33     53       Helical. {ECO:0000250|UniProtKB:P00157}.
FT   TRANSMEM     77     98       Helical. {ECO:0000250|UniProtKB:P00157}.
FT   TRANSMEM    113    133       Helical. {ECO:0000250|UniProtKB:P00157}.
FT   TRANSMEM    178    198       Helical. {ECO:0000250|UniProtKB:P00157}.
FT   TRANSMEM    226    246       Helical. {ECO:0000250|UniProtKB:P00157}.
FT   TRANSMEM    288    308       Helical. {ECO:0000250|UniProtKB:P00157}.
FT   TRANSMEM    320    340       Helical. {ECO:0000250|UniProtKB:P00157}.
FT   TRANSMEM    347    367       Helical. {ECO:0000250|UniProtKB:P00157}.
FT   METAL        83     83       Iron 1 (heme b562 axial ligand).
FT                                {ECO:0000250|UniProtKB:P00157}.
FT   METAL        97     97       Iron 2 (heme b566 axial ligand).
FT                                {ECO:0000250|UniProtKB:P00157}.
FT   METAL       182    182       Iron 1 (heme b562 axial ligand).
FT                                {ECO:0000250|UniProtKB:P00157}.
FT   METAL       196    196       Iron 2 (heme b566 axial ligand).
FT                                {ECO:0000250|UniProtKB:P00157}.
FT   BINDING     201    201       Ubiquinone.
FT                                {ECO:0000250|UniProtKB:P00157}.
FT   VARIANT       7      7       T -> I (in dbSNP:rs3135031).
FT                                {ECO:0000244|PubMed:21269460,
FT                                ECO:0000269|PubMed:10453733,
FT                                ECO:0000269|PubMed:11130070,
FT                                ECO:0000269|PubMed:11553319,
FT                                ECO:0000269|PubMed:12022039,
FT                                ECO:0000269|PubMed:1757091,
FT                                ECO:0000269|PubMed:7530363,
FT                                ECO:0000269|PubMed:7623448}.
FT                                /FTId=VAR_008585.
FT   VARIANT       8      8       N -> S (in dbSNP:rs28357679).
FT                                {ECO:0000269|PubMed:10453733,
FT                                ECO:0000269|PubMed:11130070,
FT                                ECO:0000269|PubMed:11553319}.
FT                                /FTId=VAR_013643.
FT   VARIANT      18     18       F -> L (in dbSNP:rs28357681).
FT                                {ECO:0000269|PubMed:10453733,
FT                                ECO:0000269|PubMed:11130070,
FT                                ECO:0000269|PubMed:11553319}.
FT                                /FTId=VAR_013644.
FT   VARIANT      34     34       G -> S (in mitochondrial myopathy;
FT                                sporadic; dbSNP:rs207459998).
FT                                {ECO:0000269|PubMed:10502593}.
FT                                /FTId=VAR_013645.
FT   VARIANT      35     35       S -> P (in exercice intolerance; with
FT                                cardiomyopathy and septo-optic dysplasia;
FT                                dbSNP:rs207460004).
FT                                {ECO:0000269|PubMed:11891837}.
FT                                /FTId=VAR_033058.
FT   VARIANT      39     39       A -> T (in dbSNP:rs2853505).
FT                                {ECO:0000269|PubMed:12022039}.
FT                                /FTId=VAR_015571.
FT   VARIANT      39     39       A -> V. {ECO:0000269|PubMed:11130070}.
FT                                /FTId=VAR_013646.
FT   VARIANT      78     78       I -> T (in dbSNP:rs200786872).
FT                                {ECO:0000269|PubMed:11130070}.
FT                                /FTId=VAR_013647.
FT   VARIANT      78     78       I -> V (in dbSNP:rs199997767).
FT                                {ECO:0000269|PubMed:12022039}.
FT                                /FTId=VAR_015572.
FT   VARIANT      80     80       R -> H (in colorectal cancer;
FT                                dbSNP:rs207459995).
FT                                {ECO:0000269|PubMed:9806551}.
FT                                /FTId=VAR_008388.
FT   VARIANT      87     87       A -> P. {ECO:0000269|PubMed:1757091}.
FT                                /FTId=VAR_008586.
FT   VARIANT     122    122       A -> T (in dbSNP:rs28357685).
FT                                {ECO:0000269|PubMed:11130070,
FT                                ECO:0000269|PubMed:11553319}.
FT                                /FTId=VAR_013648.
FT   VARIANT     123    123       T -> A. {ECO:0000269|PubMed:11130070}.
FT                                /FTId=VAR_013649.
FT   VARIANT     151    151       S -> P (in exercise intolerance;
FT                                dbSNP:rs207460001).
FT                                {ECO:0000269|PubMed:11464242}.
FT                                /FTId=VAR_013650.
FT   VARIANT     153    153       I -> T (in dbSNP:rs28357687).
FT                                {ECO:0000269|PubMed:11130070}.
FT                                /FTId=VAR_013651.
FT   VARIANT     164    164       I -> V (in dbSNP:rs201250154).
FT                                {ECO:0000269|PubMed:11553319}.
FT                                /FTId=VAR_013652.
FT   VARIANT     166    166       G -> E (in hyperthrophic cardiomyopathy;
FT                                dbSNP:rs193302990).
FT                                {ECO:0000269|PubMed:10453733}.
FT                                /FTId=VAR_013653.
FT   VARIANT     171    171       D -> N (in LHON; secondary mutation; does
FT                                not seem to directly cause the disease;
FT                                dbSNP:rs41518645).
FT                                {ECO:0000269|PubMed:1732158}.
FT                                /FTId=VAR_002197.
FT   VARIANT     189    190       IA -> VT.
FT                                /FTId=VAR_013654.
FT   VARIANT     191    191       A -> T (in dbSNP:rs2853507).
FT                                {ECO:0000269|PubMed:12022039,
FT                                ECO:0000269|PubMed:7530363}.
FT                                /FTId=VAR_011339.
FT   VARIANT     194    194       T -> A (in dbSNP:rs2853508).
FT                                {ECO:0000269|PubMed:10453733,
FT                                ECO:0000269|PubMed:11130070,
FT                                ECO:0000269|PubMed:11553319,
FT                                ECO:0000269|PubMed:12022039,
FT                                ECO:0000269|PubMed:7530363}.
FT                                /FTId=VAR_011340.
FT   VARIANT     229    229       A -> T (in dbSNP:rs2853509).
FT                                {ECO:0000269|PubMed:11130070,
FT                                ECO:0000269|PubMed:11553319,
FT                                ECO:0000269|PubMed:7530363}.
FT                                /FTId=VAR_011341.
FT   VARIANT     236    236       L -> I (in dbSNP:rs3088309).
FT                                {ECO:0000269|PubMed:10453733,
FT                                ECO:0000269|PubMed:11130070,
FT                                ECO:0000269|PubMed:11553319}.
FT                                /FTId=VAR_013655.
FT   VARIANT     251    258       Missing (in mitochondrial myopathy;
FT                                sporadic). {ECO:0000269|PubMed:10502593}.
FT                                /FTId=VAR_013657.
FT   VARIANT     251    251       G -> D (in CMIH; dbSNP:rs207460003).
FT                                {ECO:0000269|PubMed:10960495}.
FT                                /FTId=VAR_013656.
FT   VARIANT     251    251       G -> S (associated with susceptibility to
FT                                obesity; dbSNP:rs199951903).
FT                                {ECO:0000269|PubMed:12905068}.
FT                                /FTId=VAR_033059.
FT   VARIANT     255    255       N -> H (in cardiomyopathy; fatal; post-
FT                                partum). {ECO:0000269|PubMed:7623448}.
FT                                /FTId=VAR_013658.
FT   VARIANT     260    260       N -> D. {ECO:0000269|PubMed:12022039}.
FT                                /FTId=VAR_015573.
FT   VARIANT     276    276       F -> L (in colorectal cancer;
FT                                dbSNP:rs207459996).
FT                                {ECO:0000269|PubMed:9806551}.
FT                                /FTId=VAR_008389.
FT   VARIANT     278    278       Y -> C (in multisystem disorder;
FT                                dbSNP:rs207460002).
FT                                {ECO:0000269|PubMed:11601507}.
FT                                /FTId=VAR_013659.
FT   VARIANT     290    290       G -> D (in exercise intolerance;
FT                                dbSNP:rs207459997).
FT                                {ECO:0000269|PubMed:8910895}.
FT                                /FTId=VAR_013660.
FT   VARIANT     306    306       I -> T (in dbSNP:rs369851331).
FT                                {ECO:0000269|PubMed:11130070}.
FT                                /FTId=VAR_013661.
FT   VARIANT     316    316       M -> T (in dbSNP:rs200975632).
FT                                {ECO:0000269|PubMed:10453733}.
FT                                /FTId=VAR_013662.
FT   VARIANT     329    329       A -> T. {ECO:0000269|PubMed:11130070}.
FT                                /FTId=VAR_013663.
FT   VARIANT     330    330       A -> T. {ECO:0000269|PubMed:11553319}.
FT                                /FTId=VAR_013664.
FT   VARIANT     334    334       I -> V. {ECO:0000269|PubMed:11130070}.
FT                                /FTId=VAR_013665.
FT   VARIANT     339    339       G -> E (in mitochondrial myopathy).
FT                                {ECO:0000269|PubMed:9818877}.
FT                                /FTId=VAR_002198.
FT   VARIANT     353    353       V -> M. {ECO:0000269|PubMed:11130070}.
FT                                /FTId=VAR_013666.
FT   VARIANT     356    356       V -> M (in LHON; secondary mutation; does
FT                                not seem to directly cause the disease;
FT                                dbSNP:rs200336777).
FT                                {ECO:0000269|PubMed:11130070,
FT                                ECO:0000269|PubMed:1732158}.
FT                                /FTId=VAR_002199.
FT   VARIANT     360    360       T -> A (in dbSNP:rs28357376).
FT                                {ECO:0000269|PubMed:11553319}.
FT                                /FTId=VAR_013667.
FT   VARIANT     368    368       T -> I (in dbSNP:rs202225494).
FT                                {ECO:0000269|PubMed:11130070,
FT                                ECO:0000269|PubMed:11553319}.
FT                                /FTId=VAR_013668.
SQ   SEQUENCE   380 AA;  42718 MW;  600E520C262E5498 CRC64;
     MTPMRKTNPL MKLINHSFID LPTPSNISAW WNFGSLLGAC LILQITTGLF LAMHYSPDAS
     TAFSSIAHIT RDVNYGWIIR YLHANGASMF FICLFLHIGR GLYYGSFLYS ETWNIGIILL
     LATMATAFMG YVLPWGQMSF WGATVITNLL SAIPYIGTDL VQWIWGGYSV DSPTLTRFFT
     FHFILPFIIA ALATLHLLFL HETGSNNPLG ITSHSDKITF HPYYTIKDAL GLLLFLLSLM
     TLTLFSPDLL GDPDNYTLAN PLNTPPHIKP EWYFLFAYTI LRSVPNKLGG VLALLLSILI
     LAMIPILHMS KQQSMMFRPL SQSLYWLLAA DLLILTWIGG QPVSYPFTII GQVASVLYFT
     TILILMPTIS LIENKMLKWA
//
